Prognostic value of inducible myocardial ischemia in predicting cardiovascular events after renal transplantation

Kidney International

Volumn 66, Issue 4, 2004, Pages 1633-1639

  Dussol, Bertrand ^a   Bonnet, Jean Louis ^b   Sampol, Jerome ^b   Savin, Bernard ^b   De La Forte, Catherine ^b   Mundler, Olivier ^b   Habib, Gilbert ^b   Morange, Sophie ^b   Barrau, Karine ^b   Loundoun, Anderson ^b   Vacher Coponat, Henri ^b   Berland, Yvon ^b  

^a HÔPITAL DE LA CONCEPTION   (France)

^b NONE

Author keywords

Coronary angiography; Coronary artery disease; Cox model; Inducible myocardial ischemia; Multivariate analysis; Noninvasive stress tests; Renal transplantation

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE; THALLIUM;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; EXERCISE TEST; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; SUDDEN DEATH;

EID: 4644305364     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00929.x     Document Type: Article

References (30)

1. FOLEY RN, PARFREY PS, SARNAK MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-S119, 1998
2. HOWARD RJ, PATTON PR, REED AI, et al: The changing causes of graft loss and death after kidney transplantation. Transplantation 73:1923-1928, 2002
3. LINDHOLM A, ALBRECHTSEN D, FRÖDIN L, et al: Ischemic heart disease: Major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 60:451-457, 1995
4. MATAS AJ, HUMAR A, GILLINGHAM KJ, et al: Five preventable causes of kidney graft loss in the 1990s: A single center analysis. Kidney Int 62:704-714, 2002
5. KASISKE BL, GUIJARRO C, MASSY ZA, et al: Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7:158-165, 1996
6. KASISKE BL: Ischemic heart disease after renal transplantation. Kidney Int 61:356-369, 2002
7. ROSTAND SG: Coronary heart disease in chronic renal insufficiency: Some management considerations. J Am Soc Nephrol 11:1948-1956, 2000
8. PARFREY PS, FOLEY RN: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 10:1606-1615, 1999
9. AAKHUS S, DAHL K, WIDEROE TE: Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant 14:648-654, 1999
10. MANN JF, GERSTEIN HC, POGUE J, et al: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134:629-636, 2001
11. BEDDHU S, ALLEN-BRADY K, CHEUNG AK, et al: Impact of renal failure on the risk of myocardial infarction and death. Kidney Int 62:1776-1783, 2002
12. HENRY RMA, KOSTENSE PJ, Bos G, et al: Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn study. Kidney Int 62:1402-1407, 2002
13. DUCLOUX D, CHALLIER B, SAAS PH, et al: CD4 cell lymphopenia and atherosclerosis in renal transplant recipients. J Am Soc Nephrol 14:767-772, 2003
14. KASISKE BL, CHAKKERA HA, ROEL J: Explained and unexplained ischemic heart disease after renal transplantation. J Am Soc Nephrol 11:1735-1743, 2000
15. KASISKE BL: Epidemiology of cardiovascular disease after renal transplantation. Transplantation 72:S5-S8, 2001
16. SCHMIDT A, STEFENELLI T, SCHUSTER E, MAYER G: Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis 37:56-63, 2001
17. KASISKE BL, RAMOS EL, GASTON RS, et al: The evaluation of renal transplant candidates: Clinical practice guidelines. Patient care and education committee of the American Society of Transplant Physicians. J Am Soc Nephrol 6:1-34, 1995
18. ROSTAND SG, KIRK KA, RUTSKY EA: Dialysis associated ischemic heart disease: Insights from coronary angiography. Kidney Int 25:653-659, 1984
19. COHN PF: Silent myocardial ischemia: An update. Adv Intern Med 34:377-392, 1989
20. MILAN STUDY ON ATHEROSCLEROSIS AND DIABETES (MISAD) GROUP: Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Am J Cardiol 79:134-139, 1997
21. JANAND-DELENNE B, SAVIN B, HABIB G, et al: Silent myocardial ischemia in patients with diabetes. Diabetes Care 22:1396-1400, 1999
22. GOTTLIEB SO, GOTTLIEB SH, ACHUFF SC, et al: Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients. JAMA 259:1030-1035, 1988
23. ROSTAND SG, RUTSKY EA: Cardiac disease in dialysis patients, in Clinical Dialysis, 3rd ed., edited by Nissenson AR, Fine RN, Gentile DE, Norwalk CT, Appleton and Lange, 1995, pp 652-698
24. RACUSEN LC, SOLEZ K, COLVIN RB, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713-723, 1999
25. DERFLER K, KLETTER K, BALCKE P, et al: Predictive value of thallium-201-dipyridamole myocardial stress scintigraphy in chronic hemodialysis patients and transplant recipients. Clin Nephrol 36:192-202, 1991
26. KASISKE BL, SNYDER JJ, GILBERTSON D, et al: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3:178-185, 2003
27. COSIO FG, PESAVENTO TE, KIM S, et al: Patient survival after renal transplantation: Impact of post-transplant diabetes. Kidney Int 62:1440-1446, 2002
28. THE HEART OUTCOMES PREVENTION EVALUATION STUDY INVESTIGATORS: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342:145-153, 2000
29. COLLINS R, ARMITAGE J, PARISH S, et al: Heart Protection Study Collaborative group: MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial. Lancet 361:2005-2016, 2003
30. ELHENDY A, MODESTO KM, MAHONEY DW, et al: Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data. J Am Coll Cardiol 41:129-135, 2003